Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5830 record(s)

Req # A-2024-000352

Adverse Drug Reaction (ADR) for Metoclopramide Hydrochloride. Report number: 001078001.

Organization: Health Canada

8 page(s)
July 2024

Req # A-2024-000373

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-103461-538, National Forum on Artifical Intelligence in Health Care: Accelerating Adoption and Responsible Use in Canada.

Organization: Health Canada

12 page(s)
July 2024

Req # A-2024-000428

Adverse Drug Reaction (ADR). Report number: 001089392.

Organization: Health Canada

7 page(s)
July 2024

Req # A-2024-000442

Adverse Drug Reactions (ADRs). Report numbers: 001088375, 001089278, 001089284, 001089287, 001089345, 001090335.

Organization: Health Canada

36 page(s)
July 2024

Req # A-2017-000542

Movapo New Drug Submission Review Reports

Organization: Health Canada

840 page(s)
July 2024

Req # A-2017-000569

Information provided to the Veterinary Drugs Directorate (VDD) in support of a New Drug Submission for VETOLEXIN 300 MG, VETOLEXIN 75 MG, and VETOLEXIN 750 MG (Drug Identification Numbers (DINs) 02463369, 02463350, 02463385 respectively).…

Organization: Health Canada

116 page(s)
July 2024

Req # A-2020-000580

All documents related to enforcement regarding, or seizures of, STLTH or Sorbae vaping products under the Tobacco and Vaping Products Act.

Organization: Health Canada

1381 page(s)
July 2024

Req # A-2020-001404

Provide the earliest or early versions of Guide 116 and Guide 117 as well as the most recent versions of the same documents that have been prepared for approval, along with any associated emails related to their development, records of decisions and…

Organization: Health Canada

1349 page(s)
July 2024

Req # A-2021-000330

Communications (letters and emails) sent to Health Canada from health professionals, regarding the risks to people receiving COVID-19 vaccines. Between December 1, 2020, and Jun 23, 2021.

Organization: Health Canada

141 page(s)
July 2024

Req # A-2021-001539

All relevant documents/records/services provided to the department to/from Kader Kourad regarding a sole sourced contract of $39,945.50 rendered on January 15 2021 for “Health Science Consultants”, as described in Q-568 on March 22 2021.

Organization: Health Canada

571 page(s)
July 2024
Date modified: